middle.news
Orthocell Scores First Commercial Sales of Remplir™ in Hong Kong, Boosting Asian Expansion
9:27am on Wednesday 10th of December, 2025 AEDT
•
Healthcare
Read Story
Orthocell Scores First Commercial Sales of Remplir™ in Hong Kong, Boosting Asian Expansion
9:27am on Wednesday 10th of December, 2025 AEDT
Key Points
First commercial sales of Remplir™ in Hong Kong achieved
Remplir now sold in Australia, New Zealand, Singapore, US, and Hong Kong
Canada and Thailand sales expected soon
New Asia Pacific Commercial Director appointed to accelerate growth
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE